Sailong Pharmaceutical Group News

Cailong Pharmaceutical-IPO Research (No. 158): Leading Brain Protector Pharmaceutical Company

中信建投Dec 3, 2017 00:00

Comments on Cylon Pharmaceutical (002898) Quarterly report: business growth exceeds expectations and follow-up products will be produced.

招商證券Oct 20, 2017 00:00

Cylon Pharmaceutical (002898) New share Analysis: neurosystematized drugs High quality Target layout Digestive systematized Drug Declaration

招商證券Sep 13, 2017 00:00

Research report on New shares of Cylon Pharmaceutical Industry (002898): important Pharmaceutical Enterprises of brain Protective agents in China

興業證券Sep 12, 2017 00:00

Cylon Pharmaceutical (002898) New share report: excellent Pharmaceutical Enterprises with the Development of Cooperative production Mode

上海證券Sep 4, 2017 00:00

Cylon Pharmaceutical (002898) Inquiry report on New shares

華鑫證券Aug 22, 2017 00:00